|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
11 a.a.
|
 |
|
|
|
|
|
|
|
131 a.a.
|
 |
|
|
|
|
|
|
|
97 a.a.
|
 |
|
|
|
|
|
|
|
54 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Complex (serine protease/inhibitor)
|
 |
|
Title:
|
 |
Bovine chymotrypsin complexed to appi
|
|
Structure:
|
 |
Bovine chymotrypsin. Chain: a, f. Bovine chymotrypsin. Chain: b, g. Engineered: yes. Bovine chymotrypsin. Chain: c, h. Engineered: yes. Protease inhibitor domain of alzheimer's amyloid beta-
|
|
Source:
|
 |
Bos taurus. Cattle. Organism_taxid: 9913. Organ: pancreatic. Gene: a4. Expressed in: escherichia coli. Expression_system_taxid: 562. Homo sapiens. Human.
|
|
Biol. unit:
|
 |
Not given
|
|
Resolution:
|
 |
|
2.10Å
|
R-factor:
|
0.215
|
R-free:
|
0.323
|
|
|
Authors:
|
 |
A.J.Scheidig,A.A.Kossiakoff
|
|
Key ref:
|
 |
A.J.Scheidig
et al.
(1997).
Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
Protein Sci,
6,
1806-1824.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Jan-97
|
Release date:
|
23-Jul-97
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P00766
(CTRA_BOVIN) -
Chymotrypsinogen A from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
245 a.a.
11 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P00766
(CTRA_BOVIN) -
Chymotrypsinogen A from Bos taurus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
245 a.a.
131 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, F, G, H:
E.C.3.4.21.1
- chymotrypsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Preferential cleavage: Tyr-|-Xaa, Trp-|-Xaa, Phe-|-Xaa, Leu-|-Xaa.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Protein Sci
6:1806-1824
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structures of bovine chymotrypsin and trypsin complexed to the inhibitor domain of Alzheimer's amyloid beta-protein precursor (APPI) and basic pancreatic trypsin inhibitor (BPTI): engineering of inhibitors with altered specificities.
|
|
A.J.Scheidig,
T.R.Hynes,
L.A.Pelletier,
J.A.Wells,
A.A.Kossiakoff.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structures of the inhibitor domain of Alzheimer's amyloid
beta-protein precursor (APPI) complexed to bovine chymotrypsin (C-APPI) and
trypsin (T-APPI) and basic pancreatic trypsin inhibitor (BPTI) bound to
chymotrypsin (C-BPTI) have been solved and analyzed at 2.1 A, 1.8 A, and 2.6 A
resolution, respectively. APPI and BPTI belong to the Kunitz family of
inhibitors, which is characterized by a distinctive tertiary fold with three
conserved disulfide bonds. At the specificity-determining site of these
inhibitors (P1), residue 15(I)4 is an arginine in APPI and a lysine in BPTI,
residue types that are counter to the chymotryptic hydrophobic specificity. In
the chymotrypsin complexes, the Arg and Lys P1 side chains of the inhibitors
adopt conformations that bend away from the bottom of the binding pocket to
interact productively with elements of the binding pocket other than those
observed for specificity-matched P1 side chains. The stereochemistry of the
nucleophilic hydroxyl of Ser 195 in chymotrypsin relative to the scissile P1
bond of the inhibitors is identical to that observed for these groups in the
trypsin-APPI complex, where Arg 15(I) is an optimal side chain for tryptic
specificity. To further evaluate the diversity of sequences that can be
accommodated by one of these inhibitors, APPI, we used phage display to randomly
mutate residues 11, 13, 15, 17, and 19, which are major binding determinants.
Inhibitors variants were selected that bound to either trypsin or chymotrypsin.
As expected, trypsin specificity was principally directed by having a basic side
chain at P1 (position 15); however, the P1 residues that were selected for
chymotrypsin binding were His and Asn, rather than the expected large
hydrophobic types. This can be rationalized by modeling these hydrophilic side
chains to have similar H-bonding interactions to those observed in the
structures of the described complexes. The specificity, or lack thereof, for the
other individual subsites is discussed in the context of the "allowed" residues
determined from a phage display mutagenesis selection experiment.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.J.Farady,
and
C.S.Craik
(2010).
Mechanisms of macromolecular protease inhibitors.
|
| |
Chembiochem,
11,
2341-2346.
|
 |
|
|
|
|
 |
C.Li,
M.Pazgier,
C.Li,
W.Yuan,
M.Liu,
G.Wei,
W.Y.Lu,
and
W.Lu
(2010).
Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions.
|
| |
J Mol Biol,
398,
200-213.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.J.Diller,
C.Humblet,
X.Zhang,
and
L.M.Westerhoff
(2010).
Computational alanine scanning with linear scaling semiempirical quantum mechanical methods.
|
| |
Proteins,
78,
2329-2337.
|
 |
|
|
|
|
 |
K.M.Dunse,
Q.Kaas,
R.F.Guarino,
P.A.Barton,
D.J.Craik,
and
M.A.Anderson
(2010).
Molecular basis for the resistance of an insect chymotrypsin to a potato type II proteinase inhibitor.
|
| |
Proc Natl Acad Sci U S A,
107,
15016-15021.
|
 |
|
|
|
|
 |
M.A.Qasim,
J.Song,
J.L.Markley,
and
M.Laskowski
(2010).
Cleavage of peptide bonds bearing ionizable amino acids at P(1) by serine proteases with hydrophobic S(1) pocket.
|
| |
Biochem Biophys Res Commun,
400,
507-510.
|
 |
|
|
|
|
 |
M.A.Salameh,
J.L.Robinson,
D.Navaneetham,
D.Sinha,
B.J.Madden,
P.N.Walsh,
and
E.S.Radisky
(2010).
The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin.
|
| |
J Biol Chem,
285,
1939-1949.
|
 |
|
|
|
|
 |
S.A.Assi,
T.Tanaka,
T.H.Rabbitts,
and
N.Fernandez-Fuentes
(2010).
PCRPi: Presaging Critical Residues in Protein interfaces, a new computational tool to chart hot spots in protein interfaces.
|
| |
Nucleic Acids Res,
38,
e86.
|
 |
|
|
|
|
 |
S.Qin,
and
H.X.Zhou
(2010).
Selection of near-native poses in CAPRI rounds 13-19.
|
| |
Proteins,
78,
3166-3173.
|
 |
|
|
|
|
 |
C.J.Farady,
P.F.Egea,
E.L.Schneider,
M.R.Darragh,
and
C.S.Craik
(2008).
Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition.
|
| |
J Mol Biol,
380,
351-360.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Dell'orco,
and
P.G.De Benedetti
(2008).
Quantitative structure-activity relationship analysis of canonical inhibitors of serine proteases.
|
| |
J Comput Aided Mol Des,
22,
469-478.
|
 |
|
|
|
|
 |
S.Macedo-Ribeiro,
C.Almeida,
B.M.Calisto,
T.Friedrich,
R.Mentele,
J.Stürzebecher,
P.Fuentes-Prior,
and
P.J.Pereira
(2008).
Isolation, cloning and structural characterisation of boophilin, a multifunctional Kunitz-type proteinase inhibitor from the cattle tick.
|
| |
PLoS ONE,
3,
e1624.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Shulman-Peleg,
M.Shatsky,
R.Nussinov,
and
H.J.Wolfson
(2007).
Spatial chemical conservation of hot spot interactions in protein-protein complexes.
|
| |
BMC Biol,
5,
43.
|
 |
|
|
|
|
 |
M.Sherawat,
P.Kaur,
M.Perbandt,
C.Betzel,
W.A.Slusarchyk,
G.S.Bisacchi,
C.Chang,
B.L.Jacobson,
H.M.Einspahr,
and
T.P.Singh
(2007).
Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
|
| |
Acta Crystallogr D Biol Crystallogr,
63,
500-507.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.González,
T.Pons,
J.Gil,
V.Besada,
M.Alonso-del-Rivero,
A.S.Tanaka,
M.S.Araujo,
and
M.A.Chávez
(2007).
Characterization and comparative 3D modeling of CmPI-II, a novel 'non-classical' Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca).
|
| |
Biol Chem,
388,
1183-1194.
|
 |
|
|
|
|
 |
E.S.Radisky,
J.M.Lee,
C.J.Lu,
and
D.E.Koshland
(2006).
Insights into the serine protease mechanism from atomic resolution structures of trypsin reaction intermediates.
|
| |
Proc Natl Acad Sci U S A,
103,
6835-6840.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Li,
B.Zhao,
Z.Cui,
J.Gan,
M.K.Sakharkar,
and
P.Kangueane
(2006).
Identification of hot spot residues at protein-protein interface.
|
| |
Bioinformation,
1,
121-126.
|
 |
|
|
|
|
 |
N.Singh,
T.Jabeen,
S.Sharma,
I.Roy,
M.N.Gupta,
S.Bilgrami,
R.K.Somvanshi,
S.Dey,
M.Perbandt,
C.Betzel,
A.Srinivasan,
and
T.P.Singh
(2005).
Detection of native peptides as potent inhibitors of enzymes. Crystal structure of the complex formed between treated bovine alpha-chymotrypsin and an autocatalytically produced fragment, IIe-Val-Asn-Gly-Glu-Glu-Ala-Val-Pro-Gly-Ser-Trp-Pro-Trp, at 2.2 angstroms resolution.
|
| |
FEBS J,
272,
562-572.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Keil,
R.Huber,
W.Bode,
and
M.E.Than
(2004).
Cloning, expression, crystallization and initial crystallographic analysis of the C-terminal domain of the amyloid precursor protein APP.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
1614-1617.
|
 |
|
|
|
|
 |
A.Nagy,
M.Trexler,
and
L.Patthy
(2003).
Expression, purification and characterization of the second Kunitz-type protease inhibitor domain of the human WFIKKN protein.
|
| |
Eur J Biochem,
270,
2101-2107.
|
 |
|
|
|
|
 |
F.Santamaria,
Z.Wu,
C.Boulègue,
G.Pál,
and
W.Lu
(2003).
Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
|
| |
J Mol Recognit,
16,
131-138.
|
 |
|
|
|
|
 |
G.M.Süel,
S.W.Lockless,
M.A.Wall,
and
R.Ranganathan
(2003).
Evolutionarily conserved networks of residues mediate allosteric communication in proteins.
|
| |
Nat Struct Biol,
10,
59-69.
|
 |
|
|
|
|
 |
M.Laskowski,
M.A.Qasim,
and
Z.Yi
(2003).
Additivity-based prediction of equilibrium constants for some protein-protein associations.
|
| |
Curr Opin Struct Biol,
13,
130-139.
|
 |
|
|
|
|
 |
O.Buczek,
K.Koscielska-Kasprzak,
D.Krowarsch,
M.Dadlez,
and
J.Otlewski
(2002).
Analysis of serine proteinase-inhibitor interaction by alanine shaving.
|
| |
Protein Sci,
11,
806-819.
|
 |
|
|
|
|
 |
M.L.Lamb,
K.W.Burdick,
S.Toba,
M.M.Young,
A.G.Skillman,
X.Zou,
J.R.Arnold,
and
I.D.Kuntz
(2001).
Design, docking, and evaluation of multiple libraries against multiple targets.
|
| |
Proteins,
42,
296-318.
|
 |
|
|
|
|
 |
V.J.Nesatyy
(2001).
Gas-phase binding of non-covalent protein complexes between bovine pancreatic trypsin inhibitor and its target enzymes studied by electrospray ionization tandem mass spectrometry.
|
| |
J Mass Spectrom,
36,
950-959.
|
 |
|
|
|
|
 |
W.R.Rypniewski,
P.R.Ostergaard,
M.Nørregaard-Madsen,
M.Dauter,
and
K.S.Wilson
(2001).
Fusarium oxysporum trypsin at atomic resolution at 100 and 283 K: a study of ligand binding.
|
| |
Acta Crystallogr D Biol Crystallogr,
57,
8.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Czapinska,
and
J.Otlewski
(1999).
Structural and energetic determinants of the S1-site specificity in serine proteases.
|
| |
Eur J Biochem,
260,
571-595.
|
 |
|
|
|
|
 |
L.Kiczak,
K.Koscielska,
J.Otlewski,
M.Czerwinski,
and
M.Dadlez
(1999).
Phage display selection of P1 mutants of BPTI directed against five different serine proteinases.
|
| |
Biol Chem,
380,
101-105.
|
 |
|
|
|
|
 |
R.Helland,
G.I.Berglund,
J.Otlewski,
W.Apostoluk,
O.A.Andersen,
N.P.Willassen,
and
A.O.Smalås
(1999).
High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
|
| |
Acta Crystallogr D Biol Crystallogr,
55,
139-148.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Z.Malik,
S.Amir,
G.Pál,
Z.Buzás,
E.Várallyay,
J.Antal,
Z.Szilágyi,
K.Vékey,
B.Asbóth,
A.Patthy,
and
L.Gráf
(1999).
Proteinase inhibitors from desert locust, Schistocerca gregaria: engineering of both P(1) and P(1)' residues converts a potent chymotrypsin inhibitor to a potent trypsin inhibitor.
|
| |
Biochim Biophys Acta,
1434,
143-150.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
| |